Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongsai granule is a Traditional Chinese Medicine (TCM) formulation developed by The First Affiliated Hospital of Henan University of Chinese Medicine. It is specifically designed for the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) characterized by the 'phlegm heat obstructing lung' syndrome. The formulation aims to clear heat, resolve phlegm, and alleviate respiratory symptoms such as cough and dyspnea. It has been studied in pilot clinical trials to evaluate its efficacy and safety as a therapeutic intervention for patients with COPD.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tongsai granule.